Arrowhead Pharmaceuticals
ARWR
#2010
Rank
C$13.14 B
Marketcap
C$95.05
Share price
0.06%
Change (1 day)
180.35%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): -C$81.61 Million

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are C$0.57 Billion. In 2024 the company made an earning of -C$0.83 Billion a decrease over its 2023 earnings that were of -C$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$81.61 Million-90.15%
2024 -C$0.83 Billion112.45%
2023 -C$0.39 Billion87.79%
2022 -C$0.21 Billion-20.1%
2021 -C$0.26 Billion67.59%
2020 -C$0.16 Billion-347.53%
2019 C$62.64 M-245.59%
2018 -C$43.04 Million-13.17%
2017 -C$49.56 Million-52.28%
2016 -C$0.11 Billion-16.57%
2015 -C$0.13 Billion30.32%
2014 -C$95.53 Million171.62%
2013 -C$35.17 Million16.56%
2012 -C$30.18 Million107.53%
2011 -C$14.54 Million
2008 -C$51.22 Million-8.07%
2007 -C$55.71 Million70.37%
2006 -C$32.7 Million122.51%
2005 -C$14.7 Million147.41%
2004 -C$5.94 Million2002.28%
2003 -C$0.29 Million-85.61%
2002 -C$1.97 Million1371.97%
2001 -C$0.14 Million-13.45%
2000 -C$0.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alnylam Pharmaceuticals
ALNY
C$0.17 B-273.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 56.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$92.18 M-188.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-C$0.15 Billion 43.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.71 B-43,253.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-C$4.35 Billion 4,089.31%๐Ÿ‡บ๐Ÿ‡ธ USA